FDA 510(k) FDA class 2 Substantially Equivalent 🇬🇧 United Kingdom

BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mouse Monoclonal Antibody

K Number: K183102 · Decision Dec 7, 2018
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
12
Applicant Total
3
Review Days
30

Basic Information

Device Name
BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mouse Monoclonal Antibody
K Number
K183102
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
864.1860
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Leica Biosystems Newcastle Limited
Date Received
November 7, 2018
Decision Date
December 7, 2018
Product Code
MXZ
Advisory Committee
Hematology
Review Advisory Committee
PA
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MXZ Immunohistochemistry Assay, Antibody, Progesterone Receptor

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MXZ), ordered by most recent decision date.

View all

Other Clearances by Leica Biosystems Newcastle Limited

K Number Device Name
K183100 Estrogen Receptor Clone 6F11 Ready-to-Use Primary Antibody for Bond, Estrogen Receptor Clone 6F11 Liquid Concentrate Primary Antibody, Novocastra
K171753 BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16), Novocastra Liquid Mouse Monoclonal Antibody Progesterone Receptor Clone 16